Institutional Ownership
Taysha Gene Therapies Inc
CUSIP 877619106COM SHSTSHAQ1 2026
Institutional Holders
185
13F filers
Shares Held
251.60M
Aggregate institutional
Institutional Value
$1.13B
Q1 2026
Net New Holders
-6
26 new · 32 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions26
Increased70
Decreased50
Sold out32
Institutional Holders
185 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 23.56M | $105.29M | 0 | Held |
| 2 | Goldman Sachs Group Inc | 22.37M | $99.99M | +8.68M | Added |
| 3 | Avoro Capital Advisors LLC | 21.70M | $97.00M | 0 | Held |
| 4 | Blackrock, Inc. | 18.37M | $82.09M | −277.5K | Reduced |
| 5 | Vestal Point Capital, LP | 18.00M | $80.46M | +4.25M | Added |
| 6 | Morgan Stanley | 17.97M | $80.31M | −113.1K | Reduced |
| 7 | Fmr LLC | 14.32M | $64.02M | +792.9K | Added |
| 8 | Rtw Investments, LP | 13.68M | $61.15M | −2.72M | Reduced |
| 9 | State Street Corp | 11.21M | $50.10M | +419.0K | Added |
| 10 | Octagon Capital Advisors LP | 8.86M | $39.60M | 0 | Held |
175 more institutional holders on Premium
See every fund holding Taysha Gene Therapies Inc, with full quarter-over-quarter share changes.
Unlock all holders